HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis.

Abstract
MicroRNAs (miR) are a class of small ( approximately 21 nucleotide) noncoding RNAs that, in general, negatively regulate gene expression. Some miRs harboring CGIs undergo methylation-mediated silencing, a characteristic of many tumor suppressor genes. To identify such miRs in liver cancer, the miRNA expression profile was analyzed in hepatocellular carcinoma (HCC) cell lines treated with 5-azacytidine (DNA hypomethylating agent) and/or trichostatin A (histone deacetylase inhibitor). The results showed that these epigenetic drugs differentially regulate expression of a few miRs, particularly miR-1-1, in HCC cells. The CGI spanning exon 1 and intron 1 of miR-1-1 was methylated in HCC cell lines and in primary human HCCs but not in matching liver tissues. The miR-1-1 gene was hypomethylated and activated in DNMT1-/- HCT 116 cells but not in DNMT3B null cells, indicating a key role for DNMT1 in its methylation. miR-1 expression was also markedly reduced in primary human hepatocellular carcinomas compared with matching normal liver tissues. Ectopic expression of miR-1 in HCC cells inhibited cell growth and reduced replication potential and clonogenic survival. The expression of FoxP1 and MET harboring three and two miR-1 cognate sites, respectively, in their respective 3'-untranslated regions, was markedly reduced by ectopic miR-1. Up-regulation of several miR-1 targets including FoxP1, MET, and HDAC4 in primary human HCCs and down-regulation of their expression in 5-AzaC-treated HCC cells suggest their role in hepatocarcinogenesis. The inhibition of cell cycle progression and induction of apoptosis after re-expression of miR-1 are some of the mechanisms by which DNA hypomethylating agents suppress hepatocarcinoma cell growth.
AuthorsJharna Datta, Huban Kutay, Mohd W Nasser, Gerard J Nuovo, Bo Wang, Sarmila Majumder, Chang-Gong Liu, Stefano Volinia, Carlo M Croce, Thomas D Schmittgen, Kalpana Ghoshal, Samson T Jacob
JournalCancer research (Cancer Res) Vol. 68 Issue 13 Pg. 5049-58 (Jul 01 2008) ISSN: 1538-7445 [Electronic] United States
PMID18593903 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Retracted Publication)
Chemical References
  • Antineoplastic Agents
  • Enzyme Inhibitors
  • Histone Deacetylase Inhibitors
  • MicroRNAs
  • DNA (Cytosine-5-)-Methyltransferases
Topics
  • Antineoplastic Agents (pharmacology)
  • Apoptosis (genetics)
  • Carcinoma, Hepatocellular (genetics)
  • Cell Cycle (genetics)
  • Cell Proliferation
  • Cluster Analysis
  • CpG Islands (drug effects, genetics)
  • DNA (Cytosine-5-)-Methyltransferases (antagonists & inhibitors)
  • DNA Methylation
  • Disease Progression
  • Enzyme Inhibitors (pharmacology)
  • Gene Expression Profiling
  • Gene Expression Regulation, Neoplastic
  • Gene Silencing (drug effects, physiology)
  • HCT116 Cells
  • Histone Deacetylase Inhibitors
  • Humans
  • Liver Neoplasms (genetics)
  • MicroRNAs (genetics, physiology)
  • Oligonucleotide Array Sequence Analysis
  • Phenotype
  • Transfection
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: